Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Portfolio Pulse from
Labcorp is acquiring select assets of BioReference Health from OPKO Health to enhance its oncology and clinical testing services.
March 11, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
OPKO Health is selling select assets of its subsidiary BioReference Health to Labcorp.
The sale may allow OPKO Health to streamline operations and focus on its core business, but the immediate financial impact is unclear.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Labcorp is acquiring select assets from BioReference Health, enhancing its oncology and clinical testing services.
The acquisition will likely strengthen Labcorp's position in the oncology sector, potentially leading to increased revenues and market share.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80